Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis

Author(s): Chi-Hsien Huang, Chia-Chen Huang, Cheuk-Kwan Sun, Gong-Hong Lin, Wen-Hsuan Hou

Journal Name: Current Neuropharmacology

Volume 14 , Issue 3 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words “methylphenidate”, “brain injuries”, “head injuries”, and “traumatic brain injury”. Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.

Keywords: Attention, cognitive function, methylphenidate, traumatic brain injury.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [272 - 281]
Pages: 10
DOI: 10.2174/1570159X13666150514233033
Price: $65

Article Metrics

PDF: 36
PRC: 2